Extralimbic autoimmune encephalitis associated with glutamic acid decarboxylase antibodies: An underdiagnosed entity?

Epilepsy and Behavior

Volumn 21, Issue 3, 2011, Pages 306-313

  Najjar, Souhel ^a   Pearlman, Daniel ^a   Najjar, Amanda ^a   Ghiasian, Vahid ^a   Zagzag, David ^a   Devinsky, Orrin ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Autoimmune; Encephalitis; Extra limbic; Glutamic acid decarboxylase; Limbic; Seizures; Vasculitis

Indexed keywords

AZATHIOPRINE; ETIRACETAM; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN; LAMOTRIGINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXCARBAZEPINE; PREDNISONE; TOPIRAMATE;

ADULT; AGED; ANAMNESIS; ARTICLE; AUTOIMMUNE ENCEPHALITIS; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; ELECTROENCEPHALOGRAM; ENCEPHALITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE; SEROLOGY; VASCULITIS; WHOLE BODY CT;

ADULT; AGED; ANTIBODIES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; BRAIN DISEASES; FEMALE; GADOLINIUM; GLUTAMATE DECARBOXYLASE; HASHIMOTO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 79959605349     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.03.038     Document Type: Article

References (18)

1. Graus F., Saiz A., Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010, 257:509-517.
2. Malter M.P., Helmstaedter C., Urbach H., Vincent A., Bien C.G. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010, 67:470-478.
3. Saiz A., Blanco Y., Sabater L., et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553-2563.
4. Peltola J., Kulmala P., Isojärvi J., et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000, 55:46-50.
5. Blanc F., Ruppert E., Kleitz C., et al. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?. J Neurol Sci 2009, 287:69-71.
6. Ances B.M., Vitaliani R., Taylor R.A., et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005, 128:1764-1777.
7. Vernino S., Lennon V.A. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 2004, 10:7270-7275.
8. Knudsen A., Bredholt G., Storstein A., et al. Antibodies to CRMP3-4 associated with limbic encephalitis and thymoma. Clin Exp Immunol 2007, 149:1-22.
9. Mazzi G., Roia D.D., Cruciatti B., Matà S., Catapano R. Plasma exchange for anti-GAD associated non paraneoplastic limbic encephalitis. Transfus Apher Sci 2008, 39:229-233.
10. Marchiori G.C., Vaglia A., Vianello M., Bardin P.G., Giometto B. Encephalitis associated with glutamic acid decarboxylase autoantibodies. Neurology 2001, 56:814.
11. Matà S., Muscas G.C., Naldi I., et al. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 2008, 199:155-159.
12. Saidha S., Murphy S., Ronayne A., McCarthy P., Hennessy M.J., Counihan T. Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil. J Neurol 2010, 257:1035-1038.
13. Cianci V., Labate A., Lanza P., et al. Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report. Seizure 2010, 19:446-449.
14. Kobayakawa Y., Tateishi T., Kawamura N., Doi H., Ohyagi Y., Kira J. A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody. Rinsho Sinkeigaku 2010, 50:92-97.
15. Stagg C.J., Lang B., Best J.G., et al. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels. Epilepsia 2010, 51:1898-1901.
16. Liimatainen S., Peltola M., Sabater L., et al. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 2010, 51:760-767.
17. Dinkel K., Meinck H.M., Jury K.M., Karges W., Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 1998, 44:194-201.
18. Bennett S.A., Stevenson B., Staines W.A., Roberts D.C. Periodic acid-Schiff (PAS)-positive deposits in brain following kainic acid-induced seizures: relationships to fos induction, neuronal necrosis, reactive gliosis, and blood-brain barrier breakdown. Acta Neuropathol 1995, 89:126-138.